GLP-1 agonists, more commonly known as drugs to treat diabetes, mimic the activity of GLP-1 and bind to receptors in an attempt to lower glucose levels and manage metabolism in patients with T2DM [40]. This evidence concerns the gene GLP1R and type 2 diabetes mellitus.